Accent Therapeutics, Inc.

Accent Therapeutics, Inc. company information, Employees & Contact Information

Updated May 2026

Quick answer

Accent Therapeutics, Inc. is a Biotechnology Research company and founded in 2017. It has approximately 33 employees on record. Contact data was last refreshed in May 2026. Find Accent Therapeutics, Inc.'s verified employee emails, phone numbers, headquarters address, and key decision makers below.

Accent is leading the translation of RNA-modifying protein (RMP) biology into promising new therapies by combining a robust chemical biology platform with rigorous approaches to target identification and validation. Our seasoned team of drug developers is uniquely experienced to interrogate and advance small molecule therapies with far-reaching potential.

Company Details

Employees
33
Founded
-
Address
65 Hayden Ave, Lexington,massachusetts 02421,united States
Phone
(339) 970-7400
Email
co****@****tx.com.
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Lexington, Massachusetts
Looking for a particular Accent Therapeutics, Inc. employee's phone or email?

Accent Therapeutics, Inc. Questions

News

Member Spotlight: Accent Therapeutics, Inc. - Massachusetts Biotechnology Council

Member Spotlight: Accent Therapeutics, Inc. Massachusetts Biotechnology Council

Boehringer Ingelheim Obtains Novel Preclinical Oncology Program from Accent Therapeutics - Yahoo Finance

Boehringer Ingelheim Obtains Novel Preclinical Oncology Program from Accent Therapeutics Yahoo Finance

Discovery of ATX968: An Orally Available Allosteric Inhibitor of DHX9 | Journal of Medicinal Chemistry - ACS Publications

Discovery of ATX968: An Orally Available Allosteric Inhibitor of DHX9 | Journal of Medicinal Chemistry ACS Publications

Accent Therapeutics Presents New Preclinical Data on Lead Clinical Programs ATX-295 and ATX-559 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - The AI Journal

Accent Therapeutics Presents New Preclinical Data on Lead Clinical Programs ATX-295 and ATX-559 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics The AI Journal

Accent Therapeutics Closes $75 Million Series C Financing - citybiz

Accent Therapeutics Closes $75 Million Series C Financing citybiz

(IUCr) Crystal structures of the DExH-box RNA helicase DHX9 - Wiley Online Library

(IUCr) Crystal structures of the DExH-box RNA helicase DHX9 Wiley Online Library

Top Accent Therapeutics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant